Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells

Differentiation

Volumn 70, Issue 9-10, 2002, Pages 486-497

  Mueller, Margareta M ^a   Fusenig, Norbert E ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

HaCaT; Invasion and vascularization; Transplantation model; Tumor progression; Tumor stroma interaction

Indexed keywords

COLLAGENASE 3; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; THROMBOSPONDIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL TRANSFORMATION; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GRANULATION TISSUE; HUMAN; IN VIVO STUDY; INFLAMMATORY CELL; KNOCKOUT MOUSE; MICROENVIRONMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION;

EID: 0036990102     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.2002.700903.x     Document Type: Review

References (69)

1. Airola, K. and Fusenig, N.E. (2001) Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J Invest Dermatol 116:85-92.
2. Bachmeier, B.E., Boukamp, P., Lichtinghagen, R., Fusenig, N.E. and Fink, E. (2000) Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 381:497-507.
3. Bajou, K., Masson, V., Gerard, R.D., Schmitt, P.M., Albert, V., Lund, L.R., Frandsen, T.L., Brunner, N., Dano, K., Fusenig, N.E., Loskutoff, D., Collen, D., Carmeliet, P., Foidart, J.M. and Noel, A. (2001) The plasminogen activator inhibitor PAI-1 controis in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for anti-angiogenic strategies. J Cell Biol 152:777-784.
4. Bajou, K., Noel, A., Gerard, R.D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N.E., Carmeliet, P., Collen, D. and Foidart, J.M. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Medicine 4:923-928.
5. Billingham, R., Orr, J. and Woodhouse, D, (1951) Transplantation of skin components during chemical carcinogenesis with 20-methylcholanthrene. Br J Cancer 5:417-432.
6. Bleuel, K., Popp, S., Fusenig, N.E., Stanbridge, E.J. and Boukamp, P. (1999) Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci USA 96:2065-2070.
7. Borchers, A.H., Steinbauer, H., Schafer, B.S., Kramer, M. and Bowden, T. (1997) Fibroblast-Directed Expression and Localization of 92-kDa Type IV Collagenase Along the Tumor-Stroma Interface in an in Vitro Three-Dimensional Model of Human Squamous Cell Carcinoma. Molecular Carcinogenesis 19:258-266.
8. Borgstrom, P., Hillan, K.J., Sriramarao, P. and Ferrara, N. (1996) Complete inhibition of angiogenesis and growth of micro-tumours by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56:4032-4039.
9. Boukamp, P., Dzarlieva-Petrusevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N.E. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771.
10. Boukamp, P., Popp, S., Altmeyer, S., Hülsen, A., Fasching, C., Cremer, T. and Fusenig, N.E. (1997) Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes, Chromsomes & Cancer 19:201-214.
11. Boukamp, P., Stanbridge, E.J., Foo, D.Y., Cerutti, P.A. and Fusenig, N.E. (1990) c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 50:2840-2847.
12. Brauchle, M., Angermeyer, K., Hübner, G. and Werner, S. (1994) Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 9:3199-3204.
13. Breitkreutz, D., Boukamp, P., Ryle, C.M., Stark, H.J., Roop, D.R. and Fusenig, N.E. (1991) Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res 51:4402-4409.
14. Breitkreutz, D., Schoop, V.M., Mirancea, N., Baur, M., Stark, H.J. and Fusenig, N.E. (1998) Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur J Cell Biol 75:273-286.
15. Breitkreutz, D., Stark, H.J., Mirancea, N., Tomakidi, P., Steinbauer, H. and Fusenig, N.E. (1997) Integrin and basement membrane normalization in mouse grafts of human keratinocytes - Implications for epidermal homeostasis. Differentiation 61:195-209.
16. Breitkreutz, D., Stark, H.J., Plein, P., Baur, M. and Fusenig, N.E. (1993) Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2 +. Differentiation 5:201-217.
17. Bruns, C.J., Harbison, M.T., Kuniyasu, H., Eue, I. and Fidler, I.J. (1999) In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mic. Neoplasia 1(1):50-62.
18. Chang, C. and Werb, Z. (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11:37-43.
19. Chung, L.W. (1995) The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv 23:33-42.
20. Cornil, J., Theodorescu, D., Man, S., Herlin, J., Jambrosic, J. and Kerbel, R.S. (1991) Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 88:6028-6032.
21. Coussens, L. and Werb, Z. (2001) Inflammatory cells and cancer. J Exp Med 193:23-26.
22. Dingemans, K.P., Zeeman-Boeschoten¸, I.M., Keep, R.F. and Pranab, K. (1993) Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer 54:1010-1016.
23. Dinney, C.P., Fishbeck, R., Singh, R.K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C.D., Fidler, I.J., et al (1995) Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 154(4):1532-1538.
24. Dvorak, H.F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl Med 315:1650-1659.
25. Fidler, I.J. (1990) Critical factors in the biology of human cancer metastasis: Twenty-eight GHA Clowes memorial lectur. Cancer Res 50:6130-6138.
26. Fusenig, N.E. (1992) Cell interaction and epithelial differentiation. In: Freshney, R.I. (ed.) Culture of Epithelial Cells Wiley-Liss Inc., New York, pp 25-57.
27. Fusenig, N.E. (1994) Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In: Leigh I., Lane B. and Watt F. (eds.) The Keratinocyte Handbook Cambridge University Press, pp 71-94.
28. Fusenig, N.E. and Boukamp, P. (1998) Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Molecular Carcinogenesis 23:144-158.
29. Fusenig, N.E., Breitkreutz, D., Dzarlieva, R.T., Boukamp, P., Bohnert, A. and Tilgen, W. (1983) Growth and Differentiation Characteristics of Transformed Keratinocytes from Mouse and Human Skin in Vitro and In Vivo. J Invest Dermatol 81:168-175.
30. Fusenig, N.E., Valentine, E.A., Worst, P.K.M. (1980) Growth behaviour of normal and transformed mouse epidermal cells after reimplantation in vivo. In: Richards R.J., Rajan K.T. (eds.) Tissue Culture in Medical Research (II) Pergamon Press, pp 87-95.
31. Gabbert, H. (1985) Mechanisms of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev 4:293-309.
32. Gregoire, M. and Lieubeau, B. (1995) The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 14:339-350.
33. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
34. Hayward, SW, Wang, YZ, Cao, M, Hom, YK, Zhang, B and Grossfeld, GD, Sudilovsky, D and Cunha, GR. (2001) Malignant transformation in a non-tumorigenic human prostatic epithelial cell line. Cancer Research 61:8135-8142.
35. Hornung, J., Bohnert, A., Phan-Than, L., Krieg, T. and Fusenig, N.E. (1987) Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation. J Cancer Res Clin Oncol 113:325-341.
36. Johansson, N., Ala-aho, R., Uitto, V., Grenman, R., Fusenig, N.E., Lopez-Otin, C. and Kahari, V.M. (2000) Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 113:227-235.
37. Kohn, E.C., Liotta, L.A. (1995) Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 55:1856-1862.
38. Meade-Tollin, L.C., Boukamp, P., Fusenig, N.E., Bowen, C.P., Tsang, T.C. and Bowden, G.T. (1998) Differential expression of matrix metalloproteinases in activated c-ras-Ha transfected immortalized human keratinocytes. Br J Cancer 77(5):24-730.
39. Montesano, R., Pepper, M.S., Möhle-Steinlein, U., Risau, W., Wagner, E.F. and Orci, L. (1990) Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene, Cell 62:435-445.
40. Morikawa, K., Walker, S.M., Nakajima, M. Pathak, S. Jessup, J.M. and Fidler, I.J. (1988) Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48:6863-6871.
41. Mueller, M.M. and Fusenig, N.E. (1999) Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer 83(6):780-789.
42. Mueller, M.M., Peter, W., Mappes, M., Huelsen, A., Steinbauer, H., Boukamp, P., Vaccariello, M., Garlick, J. and Fusenig, N.E. (2001) Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 159(4):1567-1579.
43. Nakamura, T., Matsumoto, K., Kiritoshi, A., Tano, Y. and Nakamura, T. (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57:3305-3313.
44. Noel, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J.M., Maquoi, E., Munaut, C., Remacle, A. and Foidart, J.M. (1997) Emerging Roles for Proteinases in Cancer. Invasion Metastasis 17:221-239.
45. Noser, F.K. and Limat, A. (1987) Organotypic culture of outer root sheath cells from human hair follicles using a new culture device. In Vitro Cell & Developmental Biology 23:541-545.
46. Ogata, Y., Hara, Y., Akagi, Y., Ohkita, A., Morodomi, T., Shirouzu, K. (1998) Metastatic model of human colon cancer constructed using orthotopic implantation in nude mice. Kurume Med J 45(1):121-125.
47. Olumi, A.F., Grossfeld, G.D., Hayward, S.W., Carroll, P.R., Tisty, T.D. and Cunha, G.R. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002-5011.
48. Park, C.C., Bissell, M.J. and Barcellos-Hoff, M.H. (2000) The influence of the microenvironment on the malignant phenotype. Mo. Med Today 6:324-327.
49. Pauli, B.U. and Knudson, W. (1988) Tumor invasion: a consequence of destructive and compositional matrix alterations. Hum Pathol 19:628-639.
50. Pham, C.D., Roberts, T.P., van Bruggen, N., Melnyk, O., Mann, J., Ferrara, N., Cohen, R.L. and Brasch, R.C. (1998) Magnetic resonance imaging detects suppression of tumour vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16:225-230.
51. Ryle, C.M., Breitkreutz, P., Stark, H.J., Leigh, I.M., Steinert, P.M., Roop, D. and Fusenig, N.E. (1989) Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HaCaT and in ras-transfected tumorigenic clones. Differentiation 40:42-54.
52. Saleh, M., Stacker, S.A. and Wilks, A.F. (1996) Inhibition of growth of C6 glioma cell in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56:393-401.
53. Schoop, V., Mirancea, N. and Fusenig, N.E. (1999) Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol 112:343-353.
54. Schor, S.L., Schor, A.M., Grey, A.M. and Rushton, G. (1988) Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J Cell Sci 90:391-399.
55. Shishido, T., Yasoshima, T., Hirata, K., Denno, R., Mukaiya, M., Ura, H, Yamaguchi, K., Kawaguchi, S. and Sato, N. (1999) Establishment and characterization of human pancreatic carcinoma lines with a high metastatic potential in the liver of nude mice. Surg Today 29(6):519-525.
56. Skobe, M. (1996) Mechanisms of tumor-stroma interactions with emphasis on angiogenesis and its significance for tumor growth and invasion. Doctoral Thesis, Technische Hochschule Darmstadt, Fachbereich Biologie..
57. Skobe, M. and Fusenig, N.E. (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 95:1050-1055.
58. Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S. and Fusenig, N.E. (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nature Medicine 11:1222-1227.
59. Smith-McCune, K.K. and Weidner, N. (1994) Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800-809.
60. Stanbridge, E.J., Boulger, L.R., Franks, C.R., Garrett, J.A., Reeson, D.E., Bischop, D. and Perkins, F.T. (1975) Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice. Cancer Res 35:2203-2212.
61. Strieth, S., Hartschuh, W., Pilz, L. and Fusenig, N.E. (2000) Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br J Cancer 82:591-600.
62. Tlsty, TD. (2001) Stromal cells can contribute to oncogenic signals. Semin. Cancer Biol 11:97-104.
63. Tomakidi, P., Mirancea, N., Fusenig, N., Herold-Mende, C., Bosch, F.X. and Breitkreutz, D. (1999) Defects of basement membrane and hemidesmosome structure correlate with malignant pheno-type and stromal interactions in HaCaT-ras xenografts. Differentiation 64:263-275.
64. Tomakidi, P., Baur, M., Stark, H.J., Herold-Mende, C., Bosch, F.X., Steinbauer, H., Fusenig, N.E. and Breitkreutz, D. (2002) Differential regulation of aberrant keratins and vimentin in transplants of benign and malignant human skin keratinocytes through stromal interactions. J Pathol (in press).
65. Turner, M.A., Darragh, T. and Palefsky, J.M. (1997) Epithelialstromal interactions modulating penetration of matrigel membranes by HPV 16-immortalized keratinocytes. J Invest Dermatol 109:619-625.
66. Vajkoczy, P., Menger, M.D., Goldbrunner, R., Ge, S., Fong, A.T., Vollmar, B., Schilling, L., Ullrich, A., Hirth, K.P., Tonn, J.C., Schmiedeck, P. and Rempel, S.A. (2000) Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. Int J Cancer 87:261-268.
67. van den Hoof, A. (1988) Stromal involvement in malignant growth. Adv Cancer Res 50:159-196.
68. th edition Butterworth and Company: London.
69. Yuan, J. and Glazer, P.M. (1998) Mutagenesis induced by the tumor microenvironment. Mutat Res 400:439-446.